New blood test predicts schizophrenia risk and best treatments | Top Vip News


Mental health


Scientists say they have developed a revolutionary new blood test for schizophrenia, a chronic brain disorder that often causes delusions, hallucinations and disorganized speech.

The proof, presented Thursday in Molecular PsychiatryIt is said to assess a person’s risk of developing schizophrenia and identify the most effective treatment for that individual by analyzing biomarkers in their blood.

“Schizophrenia is difficult to diagnose, especially in its early stages, and it is very important to get people on the right treatment from the beginning,” said Dr. Alexander Niculescu, lead author of the study from the University’s School of Medicine. from Indiana. said in a statement.

“Psychosis usually manifests itself in early adulthood, a privileged period of life,” Niculescu continued. “Stress and drugs, including marijuana, are precipitating factors in a context of genetic vulnerability. If left uncontrolled, psychosis leads to the accumulation of biological, social and psychological damage.”

As many as 3.5 million Americans have been diagnosed with schizophrenia, which often presents between the late teens and early 30s. Show Stats.

Scientists say they have developed a revolutionary new blood test for schizophrenia, a chronic brain disorder that often causes delusions, hallucinations and disorganized speech. angellodeco – stock.adobe.com

Researchers analyzed the blood of psychiatric patients they followed for more than a decade and identified biomarkers that predicted extreme hallucinations and delusions and psychiatric hospitalizations related to these symptoms.

They then studied which biomarkers would be best treated with certain medications.

According to statistics, up to 3.5 million Americans have been diagnosed with schizophrenia, which often occurs between the late teens and early 30s. angellodeco – stock.adobe.com

“Fortunately, biologically some of the existing drugs work quite well if they are started early in the right patients,” Niculescu explained.

“Social support is also paramount, and once that and medications are available, psychological support and therapy can also help,” he continued. “There is still much to understand and apply about cognition and its abnormalities, but there is reason for optimism in this era of emerging precision psychiatry.”

The test is expected to be commercially available later this year.

Previous research has shown that fingerprint images may also have potential as predictors of schizophrenia.

A 2022 study used a machine learning-based process known as a convolutional neural network to find abnormalities in the fingerprints of people known to have schizophrenia.




Load more…









Copy URL to share

Leave a Comment